Floatz logo

Therapeutic Asset Ratings

388 results matching 1 filter

133,990 assets · 8,802 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Dabrafenib
Astrocytoma
Novartis PharmaceuticalsP4BB (65)
Dabrafenib
Central Neurocytoma
Novartis PharmaceuticalsP4BB (65)
Dabrafenib
Cerebellar Iponeurocytoma
Novartis PharmaceuticalsP4BB (65)
Dabrafenib
Chordoid Glioma of Third Ventricle
Novartis PharmaceuticalsP4BB (65)
Dabrafenib
Desmoplastic Infantile Astrocytoma and Ganglioglioma
Novartis PharmaceuticalsP4BB (65)
Dabrafenib
Diffuse Astrocytoma
Novartis PharmaceuticalsP4BB (65)
Dabrafenib
Dysplastic Gangliocytoma of Cerebrellum
Novartis PharmaceuticalsP4BB (65)
Dabrafenib
Extraventricular Neurocytoma
Novartis PharmaceuticalsP4BB (65)
Dabrafenib
Gangliocytoma
Novartis PharmaceuticalsP4BB (65)
Dabrafenib
Ganglioglioma
Novartis PharmaceuticalsP4BB (65)
Dabrafenib
Giant Cell Astrocytoma
Novartis PharmaceuticalsP4BB (65)
Dabrafenib
Oligodendroglioma, Childhood
Novartis PharmaceuticalsP4BB (65)
Dabrafenib
Papillary Glioneuronal Tumor
Novartis PharmaceuticalsP4BB (65)
Dabrafenib
Pilocytic Astrocytoma
Novartis PharmaceuticalsP4BB (65)
Dabrafenib
Pleomorphic Xanthoastrocytoma
Novartis PharmaceuticalsP4BB (65)
Dabrafenib
Rosette-forming Glioneurona Tumor
Novartis PharmaceuticalsP4BB (65)
gsk1120212
Angiocentric Glioma
Novartis PharmaceuticalsP4BB (65)
gsk1120212
Astrocytoma
Novartis PharmaceuticalsP4BB (65)
gsk1120212
Central Neurocytoma
Novartis PharmaceuticalsP4BB (65)
gsk1120212
Cerebellar Iponeurocytoma
Novartis PharmaceuticalsP4BB (65)
gsk1120212
Chordoid Glioma of Third Ventricle
Novartis PharmaceuticalsP4BB (65)
gsk1120212
Desmoplastic Infantile Astrocytoma and Ganglioglioma
Novartis PharmaceuticalsP4BB (65)
gsk1120212
Diffuse Astrocytoma
Novartis PharmaceuticalsP4BB (65)
gsk1120212
Dysplastic Gangliocytoma of Cerebrellum
Novartis PharmaceuticalsP4BB (65)
gsk1120212
Extraventricular Neurocytoma
Novartis PharmaceuticalsP4BB (65)
Showing 26 to 50 of 388 assets
PreviousPage 2 of 16Next